Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 5 of 5 Results
Age
Type
Conditions or Disease:

Intermediate Expanded Access Protocol (EAP) CNMAu8.EAP02

Namita Goyal

  • OPEN TO ACCRUAL

Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in ALS

Namita Goyal

  • OPEN TO ACCRUAL

Parallel Ph III for High Risk Prostate Ca Evaluating De-Intensification & Intensification of Tx

Steven Neema Seyedin

  • OPEN TO ACCRUAL

COMPASSHER2 RD Ph III Trial of T-DM1 & Placebo Compared w/ T-DM1 & Tucatinib

Ritesh Parajuli

  • OPEN TO ACCRUAL